Children's Hospital Boston 300 Longwood Avenue
Boston, MA 02115
(617) 355-6000
X
Clinical Services:
Training Record
The "graduates" of the fellowship program during the past 40 years best illustrate the success of our approach to training: 94 percent are in academic medicine and 61 percent are doing primarily laboratory or clinical research (or are administering research). Another way to look at the program is to analyze our success at achieving our major objective, which is to train leaders of American hematology and oncology. To evaluate our success in preparing fellows for leadership positions, one must consider the cohort who began training between 1966 and 1992. More recent fellows are still completing their training or are early in their academic careers.
Leadership Positions
The 1966-1992 cohort contains 108 individuals of whom 96 (90 percent) are currently in academic medicine or are recently retired from academic positions. Of these, 21 percent are or were Hospital Directors or Department Chairs, 39 percent are or were Chiefs of Divisions of Hematology/Oncology or Bone Marrow Transplantation, three percent are Heads of Other Divisions, 11 percent are Research Professor or Directors of Research, and eight percent are or were Heads of Major Clinical Programs. Thus, 82 percent of the group in academic medicine have reached positions of prominence. An additional two percent are Leaders in the Biotechnology/Biopharmaceutical Industry. Twenty percent of the group who began between 1992 and 1997 are also already in leadership positions, but most are early in their careers and have not reached their full potential.
Select Societies
A remarkable number of the graduates of our fellowship program or our other trainees are members of the institutions that guide American medicine and pediatrics and that select their members based on scientific accomplishment. No other pediatric program, in any specialty, has such a record of accomplishment by its alumni.

National Academy of Sciences and/or the Academy's Institute of Medicine - 10 members
Howard Hughes Medical Institute - 9 members
Association of American Physicians - 30 members
American Pediatric Society - 36 members
American Society of Clinical Investigation - 51 members
Society for Pediatric Research - 61 members

Five alumni have served as President of the American Society of Clinical Investigation and one as Vice-President. Five have served as President of the American Society of Hematology. Five were awarded the prestigious Dameshek Prize for Research in Hematology, four received the equally prestigious E. Donnall Thomas Prize in Hematology, and eight received the E. Mead-Johnson Award for Research in Pediatrics. These are the highest research awards in each specialty. Four received the Henry M. Stratton Medal in recognition of a distinguished career in American hematology. Finally, David Nathan, has receive both the Howland Award, the highest honor in pediatrics and the Kober Medal, the highest honor in internal medicine.

Examples
  • Herbert T. Abelson, M.D. (Assoc Dean for Admissions and ex-Chair, Dept. of Pediatrics, Chicago; ex-Chair, Univ. of Washington, Seattle)
  • Arnold J. Altman, M.D. (ex-Chief, Div. of Pediatric Hematology-Oncology, Connecticut)
  • Nancy C. Andrews, M.D., Ph.D. (Dean, Duke University School of Medicine; previously, Dean for Basic Science & Graduate Studies and HHMI Investigator, Harvard Medical School)
  • Robert J. Arceci, M.D., Ph.D. (ex-Chief, Div. of Pediatric Oncology, Dept. of Oncology, Johns Hopkins)
  • Robert Baehner, M.D. (Chair of Pediatrics Emeritus, Children's Hosp of Los Angeles, Univ of Southern Calif)
  • Edward J. Benz Jr., M.D. (President, Dana-Farber Cancer Institute, Harvard; Ex-Chair, Dept. of Medicine, Johns Hopkins)
  • Eric C. Beyer, M.D., Ph.D. (ex-Chief, Div. of Pediatric Hematology/Oncology, Chicago)
  • Barbara Bierer, M.D. (Senior Vice President for Research, Brigham and Women's Hospital, Harvard)
  • Laurence A. Boxer, M.D. (ex-Chief, Div. of Pediatric Hematology/Oncology, Michigan)
  • George Buchanan, M.D. (Chief, Div. of Pediatric Hematology/Oncology, Texas, Southwestern)
  • Steven J. Burakoff, M.D. (Director, Skirball Institute of Biomolecular Medicine, New York Univ; ex-Chai, Ped Oncology, Dana-Farber Cancer Institute)
  • Bruce M. Camitta, M.D. (ex-Chief, Section of Pediatric Hematology/Oncology, Milwaukee)
  • Luis Clavell, M.D. (Medical Director, San Jorge Children's Hospital, Univ of Puerto Rico School of Medicine)
  • Harvey J. Cohen , M.D., Ph.D. (ex-Chair, Dept. of Pediatrics, Stanford)
  • John T. Curnutte, M.D., Ph.D. (President, DNAX Research Institute, Vice-President, Schering-Plough Res. Inst.)
  • Alan D. D'Andrea M.D. (Research Director, Dept. of Radiation Oncology, Dana-Farber Cancer Institute, Harvard Medical School)
  • Albert D. Deisseroth, M.D., Ph.D. (President and CEO, Sidney Kimmel Cancer Center, San Diego)
  • Lisa R. Diller, M.D. (Chief of Clinical Pediatric Oncology, Dana-Farber Cancer Institute and Children's Hospital Boston; Director, Adult and Pediatric Cancer Survivor Program, Dana-Farber Cancer Institute, Harvard)
  • Mary C. Dinauer, M.D. (Professor and Head, Herman Wells Research Center, Dept. of Pediatrics, Indiana)
  • Stephen G. Emerson, M.D., Ph.D. (ex-Chief, Div. of Hematology/Oncology, Dept. of Medicine, Pennsylvania)
  • R. Alan B. Ezekowitz, MBChB, DPhil (Senior Vice President, Merck, Inc., ex-Chair, Dept. of Pediatrics, Massachusetts General Hospital, Harvard)
  • Douglas V. Faller, M.D., Ph.D. (Director, Cancer Research Center; Vice-Chair, Dept of Medicine, Boston Univ)
  • Stephen A. Feig, M.D. (Vice-Chair of Pediatric, UCLA, ex-Chief, Div. of Pediatric Hematology/Oncology)
  • James Ferrara, M.D. (Director, Pediatric Bone Marrow Transplantation, Michigan)
  • Nathan Fischel-Ghodsian, M.D. (Director, Molecular Hematology, Cedars-Sinai Medical Center, Los Angeles)
  • David E. Fisher, M.D., Ph.D. (Director, Melanoma Service, Dana-Farber Cancer Institute, Harvard)
  • Bernard G. Forget, M.D. (Chief, Hematology Section, Dept. of Medicine, Ex-Dean of Science, Sch. of Med., Yale)
  • Christopher Frantz, M.D. (Chief, Div of Hematol/Oncol, Alfred I. duPont Hosp for Children, Wilmington, DE)
  • Stephen H. Friend, M.D., Ph.D. (President, Rosetta Inpharmatics; Senior Vice President for Basic Research, Merck Inc.)
  • Robert Garcea, M.D. (ex-Chief, Div. of Pediatric Hematology/Oncology, Colorado)
  • David Ginsburg, M.D. (HHMI Investigator; ex-Chief, Div. of Molecular Medicine and Genetics, Dept. of Med., Michigan)
  • Bertil E. Glader, M.D. (ex-Chief, Div. of Ped Hematology/Oncology, Stanford)
  • Todd R. Golub, M.D. (Director, Cancer Genomics, Broad Institute and Dana-Farber Cancer Institute, Associate Investigator, HHMI)
  • Jed Gorlin, M.D. (VP and Medical Director, Memorial Blood Centers, Minneapolis)
  • Daniel M. Green, M.D. (ex-Chief, Division of Oncology, SUNY Buffalo)
  • Holcombe E. Grier, M.D. (Assoc Chief of Pediatric Clinical Oncology, Dana-Farber Cancer Institute, Harvard)
  • Yuet W. Kan, M.D. (Chief, Div. of Molec. Med. and Diagnostics; ex-HHMI Investigator, Univ Calif.
  • Mark W. Kieran, M.D., Ph.D. (Head, Neuro-oncology, Children's Hospital/Dana-Farber Cancer Institute)
  • Christoph Klein, M.D. (Head, Section of Exp Hematol, Dept Pediat Hematol/Oncol, Hannover, Germany)
  • Eric C. Larsen, M.D. (ex-Director, Div. of Pediatric Hematology/Oncology, Dartmouth)
  • Michael P. Link, M.D. (Chief, Div of Pediatric Hematology/Oncology, Stanford)
  • Jeffrey Lipton, M.D., Ph.D. (Chief, Div. of Pediatric Hematology/Oncology, Long Island Jewish Med. Ctr, NY)
  • Bertram H. Lubin, M.D. (Director of Medical Research, Oakland Children's Hospital, Oakland, CA)
  • Samuel E. Lux, M.D. (Vice Chair for Science; ex-Chief, Div of Hematology/Oncology, Children's Hospital Boston, Harvard Medical School)
  • William C. Mentzer, M.D. (ex-Chief, Div. of Pediatric Hematology/Oncology, Univ Calif, San Francisco)
  • Ellis J. Neufeld, M.D., Ph.D. (Assoc. Director of Hematology, Children's Hospital Boston, Harvard Medical School)
  • Peter E. Newburger, M.D. (Chief, Div. of Pediatric Hematology/Oncology, Univ Massachusetts)
  • Charlotte Niemeyer, M.D. (Professor and Head of Oncology, Univ. Children's Hospital, Freiburg, Germany)
  • Arthur W. Nienhuis, M.D. (ex-Director & CEO, St. Jude Children's Research Hospital, Memphis)
  • Stuart H. Orkin, M.D. (Chair, Dept of Pediatric Oncology, Dana-Farber Cancer Institute, Harvard; Investigator, HHMI)
  • Robertson Parkman, M.D. (ex-Chief, Bone Marrow Transplantation Service, Children's Hospital, Los Angeles)
  • Susan K. Parsons, M.D. (Dir, Ctr on Child and Family Outcomes, Inst for Clin Res'rch & Health Policy Studies, New Engl Med Ctr, Tufts)
  • Orah S. Platt, M.D. (Chair, Dept of Laboratory Medicine, Children's Hospital, Master, Castle Society, Harvard Medical School)
  • Edward V. Prochownick, M.D., Ph.D. (Director of Oncology Research, Children's Hospital, Pittsburgh)
  • Philip Rosoff, M.D. (ex-Chief, Div. of Pediatric Hematology/Oncology, Duke)
  • Marc E. Rothenberg, M.D., Ph.D. (Chief, Div of Allergy and Clinical Immunology, Cincinnati)
  • Stephen E. Sallan, M.D. (Chief of Staff and ex-Chief of Pediatric Clinical Oncology, Dana-Farber Cancer Institute, Harvard Med School)
  • Charles Scher, M.D. (Chief, Div of Hematology/Oncology, Tulane)
  • Alan L. Schwartz, M.D., Ph.D. (Chair, Dept. of Pediatrics, Washington Univ., St. Louis)
  • Elias Schwartz, M.D. (ex-Director, Med. Res., Dupont Children's Hosp; Ex-Chair, Dept of Pediatrics, CHOP)
  • George B. Segel, M.D. (Vice-Chair of Pediatrics, ex-Chief, Div. of Pediatric Hematology/Oncology, Vice-Chair of Pediatrics, Rochester)
  • Eilat Shinar, M.D. (Director, Israel Red Cross)
  • Susan Shurin, M.D. (Deputy Director, NHLBI; ex-Chief, Div. of Pediatric Hematol/Oncol, Case-Western Reserve)
  • M. Celeste Simon, Ph.D. (HHMI Investigator, Univ Pennsylvania Cancer Center, Philadelphia)
  • Thomas P. Stossel, M.D. (ex-Chief, Div. of Hematology, Dept. of Med., Brigham and Women's Hosp, Harvard)
  • Douglas Taylor, M.D. (Director, Pediatric Hematopoietic Stem Cell Transplantation, Univ California, Davis)
  • Alan S. Wayne, M.D. (Head, Hematologic Diseases Section, Pediatric Oncology Branch, NCI, NIH)
  • Howard J. Weinstein, M.D. (Chief, Div. of Pediatric Hematology/Oncology, Mass. General Hospital, Harvard)
  • Daniel C. West, M.D. (Director, Residency Training Program, Univ California, Davis)
  • David A. Williams, M.D. (Chief, Div. of Hematology/Oncology, Children's Hospital Boston, Harvard Medical School; ex-HHMI Invest.)
  • David B. Wilson, M.D., Ph.D. (ex-Chief, Div. of Pediatric Hematology/Oncology, Washington Univ., St. Louis)
  • Lawrence C. Wolfe, M.D. (Chief, Div. of Pediatric Hematology/Oncology, New Engl Med Ctr, Tufts)
  • Leonard I. Zon, M.D. (Chief, Program in Stem Cell Biology, Investigator, HHMI, Children's Hospital Boston, Harvard)
X
X The information on this website should not be taken as medical advice,
which can only be given to you by your personal health care professional.
X
X Copyright © Children's Hospital Boston. All rights reserved.